In the News
MOCA celebrated 20 years of progress – and new milestones in ovarian cancer research funding – at the MOCA Annual Meeting this week.
This year, MOCA awarded $680,000 in funding to Minnesota and national researchers, putting our total amount of funding at nearly $9 million.
The 2019 MOCA-funded researchers at the Masonic Cancer Center, University of Minnesota include:
Mighty MRI
The U’s Center for Magnetic Resonance Research keeps inventing better ways to diagnose, treat, and monitor disease
Open-water swimmer traverses the globe, raising money for breast cancer research at the Masonic Cancer Center
Six weeks before she was set to swim across the English Channel for the first time, Michelle Macy learned that her mother, Kathleen, had been diagnosed with breast cancer.
Branden Moriarity harnesses the power of genome engineering, where scientists reprogram DNA, to develop innovative immunotherapy approaches for treating highly lethal forms of cancer. Moriarity’s work, combined with that of his colleagues, was the foundation for B-MoGen Biotechnologies Inc., a University startup company launched in 2016. He currently serves as B-MoGen’s chief scientific officer. Moriarity, a Masonic Cancer Center researcher, was a winner of the 2019 Early Innovator Award.
Researchers from the University of Minnesota School of Public Health and Masonic Cancer Center, whose findings were recently published in the journal Science, have developed an innovative method for determining how toxins interact with and damage DNA on the molecular level.
